Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Practice toolkit

Regenerative Orthopedics Practice Launch & Operational Checklist

This toolkit provides a structured, step-by-step roadmap to evaluate, equip, staff, and compliantly launch a regenerative orthopedic service line.

Launching a regenerative orthopedics service line requires aligned clinical protocols, compliant biologic sourcing, trained staff, and robust cash-pay or hybrid workflow integration. This launch toolkit outlines the essential operational, regulatory, and logistical milestones needed to introduce regenerative therapies without disrupting existing practice operations. Clinicians and practice managers can use this checklist to establish a high-compliance, patient-centered procedural service line.

The checklist

  • Verify physician state medical board regulations and scope of practice guidelines for regenerative orthopedics.
  • Establish standardized, compliant informed consent documentation detailing risks, benefits, and cash-pay status.
  • Evaluate FDA regulatory classification and compliance status of all intended biologic products.
  • Secure temperature-monitored cold-chain storage equipment for biologics with continuous log tracking.
  • Source high-yield PRP, BMAC, or tissue processing supplies from verified, licensed distributors.
  • Acquire or calibrate high-resolution diagnostic ultrasound equipment for precise procedural guidance.
  • Train clinical personnel on aseptic processing, centrifuge operation, and biologic handling protocols.
  • Define clear fee schedules and transparent patient financial disclosure documentation.
  • Configure EHR templates for regenerative orthopedic initial evaluation, procedural notes, and follow-ups.
  • Establish Standard Operating Procedures (SOPs) for biohazard disposal and equipment maintenance.
  • Create objective, evidence-informed patient educational materials and post-procedure care guides.
  • Implement standardized functional outcome scoring tools to track patient progress at 3, 6, and 12 months.

Phase 1: Regulatory Compliance & Scope of Practice

Establishing a solid regulatory foundation is the critical first step in launching any regenerative service line. Practices must verify physician scope of practice guidelines, state medical board regulations, and relevant federal framework requirements governing human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Additionally, practices should establish clear, transparent informed consent templates specifically tailored to regenerative workflows. These documents must outline treatment rationale, non-covered financial terms, potential risks, and evidence-informed expectations to ensure total clarity prior to procedural scheduling.

Phase 2: Product Sourcing & Equipment Integration

Selecting reliable medical devices and compliant biologic solutions is essential for clinical repeatability and workflow safety. Evaluate suppliers based on quality management systems, FDA regulatory alignment, processing yields, and reliable delivery logistics. Review available options for biologics such as bone marrow aspirate kits, platelet-rich plasma (PRP) systems, and structural tissue matrices.

Equipping procedural rooms requires appropriate capital devices, including point-of-care ultrasound for precision guidance and temperature-monitored storage units for biologic integrity. Inventory tracking systems should be updated to log manufacturer lot numbers, expiration dates, and patient matching details for complete traceability.

Phase 3: Operational Workflows & Staff Training

Integrating procedural workflows into existing clinic schedules requires defined standard operating procedures (SOPs). Clinical staff must be trained on centrifuge operation, aseptic processing, patient preparation, and specimen handling to maintain sterile fields and prevent sample contamination.

Establish designated room scheduling blocks for regenerative consultations and procedural days. Front-desk staff, medical assistants, and billing coordinators must receive tailored training to handle patient inquiries, explain service line logistics, and manage cash-pay or non-covered fee processing efficiently.

Phase 4: Financial Structure & Patient Education

A transparent financial model prevents misunderstandings and maintains regulatory compliance. Practices should establish clear fee schedules for all regenerative procedures, consultation blocks, and post-procedure follow-up visits, utilizing detailed advance beneficiary notices or cash-pay agreement disclosures.

Patient education materials must remain objective, balanced, and compliant with regulatory guidelines. Educational brochures, website content, and intake forms should clearly explain procedural protocols, rehabilitation guidelines, and realistic clinical goals without using exaggerated marketing claims.

Phase 5: Quality Assurance & Functional Outcome Tracking

Long-term service line success relies on systematic clinical outcome tracking and continuous quality improvement. Implementing standardized baseline functional scores (such as VAS, DASH, or KOOS) allows clinicians to measure patient progress objectively at standardized interval follow-ups.

Establishing an internal quality assurance protocol ensures immediate reporting and resolution of any adverse events. Regular clinical chart reviews help maintain high standards of patient care, protocol adherence, and consistent clinical outcomes across the practice.

Questions practices ask

How long does it typically take to launch a regenerative orthopedics service line?
Most practices complete initial planning, equipment acquisition, staff training, and protocol integration within 60 to 90 days. Timeline length depends primarily on existing practice infrastructure, staff readiness, and supplier onboarding.
What imaging equipment is necessary before offering targeted biologic injections?
High-resolution point-of-care ultrasound is standard for peripheral joint injections to ensure accurate anatomical target localization and procedural documentation. Fluoroscopy may also be utilized depending on specific spinal or deep structural applications.
How should practices handle patient financial disclosures for cash-pay procedures?
Practices should provide written financial agreements prior to scheduling that explicitly outline fee structures, non-covered insurance status, payment terms, and cancellation policies. Consulting healthcare legal counsel ensures forms comply with federal and state billing regulations.
What criteria should be used when choosing a biologics distributor?
Select distributors based on regulatory compliance, product traceability, consistent kit yields, staff education resources, and reliable cold-chain supply logistics rather than price alone.

Request a consultation with our practice support team to evaluate your facility needs and explore compliant regenerative solutions. Request a consultation or browse more practice toolkits.

Talk to a regenerative supply specialist

Tell us the service line you are building and we will map the biologics, devices, and supplies that fit your protocol and margins.

  • Licensed Texas distributor since 2016
  • Protocol, training, and workflow support
  • Straight answers on cost per treatment
Request consultation

Most practices hear back the same business day.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →